Sake J. de Vlas

Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa

Marieke J. van der Werf, Sake J. de Vlas, Simon Brooker et al. · Acta Tropica · 2003 · 948 citations

Parasitic Disease, Epidemiology, Clinical Morbidity +11

Underestimation of Schistosoma mansoni prevalences

Sake J. de Vlas, B. Gryseels · Parasitology Today · 1992 · 269 citations

Parasitic Disease, Malaria, Pathology +5

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models

Jeffrey W. Eaton, Nicolas A. Menzies, John Stover et al. · The Lancet Global Health · 2013 · 244 citations · Full text

Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis

Wilma A. Stolk, Martin Walker, Luc E. Coffeng et al. · Parasites & Vectors · 2015 · 236 citations · Full text

Are poor responses to praziquantel for the treatment of <i>Schistosoma mansoni</i> infections in Senegal due to resistance? An overview of the evidence

B. Gryseels, Amadou Ibrahima Mbaye, Sake J. de Vlas et al. · Tropical Medicine & International Health · 2001 · 222 citations · Full text